"Make a difference in your community by reducing the risk of HPV-related cancers. Get your child vaccinated.
The Impact of HPV
Human papillomavirus, also known as HPV, does not discriminate. Almost everyone who is sexually active"...
Topically applied podofilox may be absorbed systemically (see CLINICAL PHARMACOLOGY section). Toxicity reported following systemic administration of podofilox in investigational use for cancer treatment included: nausea, vomiting, fever, diarrhea, bone marrow depression, and oral ulcers. Following 5 to 10 daily intravenous doses of 0.5 to 1 mg/kg/day, significant hematological toxicity occurred but was reversible. Other toxicities occurred at lower doses. Toxicity reported following systemic administration of podophyllum resin included: nausea, vomiting, fever, diarrhea, peripheral neuropathy, altered mental status, lethargy, coma, tachypnea, respiratory failure, leukocytosis, pancytosis, hematuria, renal failure, and seizures. Treatment of topical overdosage should include washing the skin free of any remaining drug and symptomatic and supportive therapy.
Condylox 0.5% Solution is contraindicated for patients who develop hypersensitivity or intolerance to any component of the formulation.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 9/23/2015
Additional Condylox Topical Information
Podofilox Topical Solution - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.